Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 44%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is a diversified home care platform that offers safe and high-quality care to medically complex, high-cost patient populations, directly addressing the pressing challenges facing the U.S. healthcare system. With its extensive technology suite and value-based care models, the company has emerged as a standard setter for high-quality pediatric care delivered in a cost-efficient manner. The strong EBITDA growth and free cash flow generation have allowed for significant deleveraging and potential for tuck-in acquisitions, making Aveanna a differentiated and well-positioned provider in the fragmented home health sub-sector.

Bears say

Aveanna Healthcare Hldgs is a diversified home care platform facing challenges such as potential government reimbursement changes, nurse availability risks in a tight labor market, and potential policy and regulatory risks. Furthermore, although the company has shown strong progress in its preferred payor strategy, there is potential for execution and integration risks in their M&A activities. Overall, the company displays potential for growth and profitability, but the risks involved and the current industry multiples support a negative outlook.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 44% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.